Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 4
1952 1
1953 7
1954 1
1955 1
1966 1
1967 1
1968 1
1970 1
1971 1
1974 1
1975 1
1976 3
1977 5
1979 3
1982 1
1983 1
1984 2
1985 1
1986 4
1987 2
1988 1
1989 1
1990 8
1991 4
1992 2
1993 3
1994 6
1995 5
1996 6
1997 6
1998 2
1999 4
2000 5
2001 2
2002 7
2003 8
2004 8
2005 7
2006 7
2007 18
2008 11
2009 11
2010 8
2011 15
2012 19
2013 20
2014 18
2015 19
2016 18
2017 17
2018 23
2019 29
2020 33
2021 47
2022 46
2023 36
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

485 results

Results by year

Filters applied: . Clear all
Page 1
Chorioamnionitis and neonatal outcomes.
Jain VG, Willis KA, Jobe A, Ambalavanan N. Jain VG, et al. Among authors: willis ka. Pediatr Res. 2022 Jan;91(2):289-296. doi: 10.1038/s41390-021-01633-0. Epub 2021 Jul 1. Pediatr Res. 2022. PMID: 34211129 Free PMC article. Review.
A hierarchy of evidence for assessing qualitative health research.
Daly J, Willis K, Small R, Green J, Welch N, Kealy M, Hughes E. Daly J, et al. Among authors: willis k. J Clin Epidemiol. 2007 Jan;60(1):43-9. doi: 10.1016/j.jclinepi.2006.03.014. Epub 2006 Sep 28. J Clin Epidemiol. 2007. PMID: 17161753 Review.
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, Greene T, Tighiouart H, Matsushita K, Ballew SH, Sang Y, Vonesh E, Ying J, Manley T, de Zeeuw D, Eckardt KU, Levin A, Perkovic V, Zhang L, Willis K. Levey AS, et al. Among authors: willis k. Am J Kidney Dis. 2020 Jan;75(1):84-104. doi: 10.1053/j.ajkd.2019.06.009. Epub 2019 Aug 28. Am J Kidney Dis. 2020. PMID: 31473020
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Derdeyn CP, et al. Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26. Lancet. 2014. PMID: 24168957 Free PMC article. Clinical Trial.
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.
Subbiah V, Chawla SP, Conley AP, Wilky BA, Tolcher A, Lakhani NJ, Berz D, Andrianov V, Crago W, Holcomb M, Hussain A, Veldstra C, Kalabus J, O'Neill B, Senne L, Rowell E, Heidt AB, Willis KM, Eckelman BP. Subbiah V, et al. Among authors: willis km. Clin Cancer Res. 2023 Aug 15;29(16):2988-3003. doi: 10.1158/1078-0432.CCR-23-0974. Clin Cancer Res. 2023. PMID: 37265425 Free PMC article. Clinical Trial.
Necrotizing enterocolitis and the gut-lung axis.
Willis KA, Ambalavanan N. Willis KA, et al. Semin Perinatol. 2021 Oct;45(6):151454. doi: 10.1016/j.semperi.2021.151454. Epub 2021 Jun 18. Semin Perinatol. 2021. PMID: 34274152 Free PMC article. Review.
Antimicrobial peptides modulate lung injury by altering the intestinal microbiota.
Abdelgawad A, Nicola T, Martin I, Halloran BA, Tanaka K, Adegboye CY, Jain P, Ren C, Lal CV, Ambalavanan N, O'Connell AE, Jilling T, Willis KA. Abdelgawad A, et al. Among authors: willis ka. Microbiome. 2023 Oct 16;11(1):226. doi: 10.1186/s40168-023-01673-0. Microbiome. 2023. PMID: 37845716 Free PMC article.
Reply to Pantaleón García et al.
Ambalavanan N, Willis KA. Ambalavanan N, et al. Among authors: willis ka. Am J Physiol Lung Cell Mol Physiol. 2022 Aug 1;323(2):L221-L222. doi: 10.1152/ajplung.00205.2022. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35944141 Free PMC article. No abstract available.
Pulmonary telangiectasia.
Currarino G, Willis KW, Johnson AF Jr, Miller WW. Currarino G, et al. Among authors: willis kw. AJR Am J Roentgenol. 1976 Nov;127(5):775-9. doi: 10.2214/ajr.127.5.775. AJR Am J Roentgenol. 1976. PMID: 788535 Review.
Reply from k.j. Willis.
Willis K. Willis K. Trends Ecol Evol. 1994 Sep;9(9):345. doi: 10.1016/0169-5347(94)90161-9. Trends Ecol Evol. 1994. PMID: 21236883 No abstract available.
485 results